These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 12860985)

  • 1. Canonical inhibitor-like interactions explain reactivity of alpha1-proteinase inhibitor Pittsburgh and antithrombin with proteinases.
    Dementiev A; Simonovic M; Volz K; Gettins PG
    J Biol Chem; 2003 Sep; 278(39):37881-7. PubMed ID: 12860985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering functional antithrombin exosites in alpha1-proteinase inhibitor that specifically promote the inhibition of factor Xa and factor IXa.
    Izaguirre G; Rezaie AR; Olson ST
    J Biol Chem; 2009 Jan; 284(3):1550-8. PubMed ID: 19010776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antithrombin P1 residue is important for target proteinase specificity but not for heparin activation of the serpin. Characterization of P1 antithrombin variants with altered proteinase specificity but normal heparin activation.
    Chuang YJ; Swanson R; Raja SM; Bock SC; Olson ST
    Biochemistry; 2001 Jun; 40(22):6670-9. PubMed ID: 11380262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.
    Filion ML; Bhakta V; Nguyen LH; Liaw PS; Sheffield WP
    Biochemistry; 2004 Nov; 43(46):14864-72. PubMed ID: 15544357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin enhances the specificity of antithrombin for thrombin and factor Xa independent of the reactive center loop sequence. Evidence for an exosite determinant of factor Xa specificity in heparin-activated antithrombin.
    Chuang YJ; Swanson R; Raja SM; Olson ST
    J Biol Chem; 2001 May; 276(18):14961-71. PubMed ID: 11278930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling of serpin-protease complexes: antithrombin-thrombin, alpha 1-antitrypsin (358Met-->Arg)-thrombin, alpha 1-antitrypsin (358Met-->Arg)-trypsin, and antitrypsin-elastase.
    Whisstock J; Lesk AM; Carrell R
    Proteins; 1996 Nov; 26(3):288-303. PubMed ID: 8953650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombin and its deficiency states.
    Lane DA; Olds RR; Thein SL
    Blood Coagul Fibrinolysis; 1992 Jun; 3(3):315-41. PubMed ID: 1643210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of antithrombin-heparin regulation of blood clotting proteinases. A paradigm for understanding proteinase regulation by serpin family protein proteinase inhibitors.
    Olson ST; Richard B; Izaguirre G; Schedin-Weiss S; Gettins PG
    Biochimie; 2010 Nov; 92(11):1587-96. PubMed ID: 20685328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of the P2 glycine of antithrombin in target proteinase specificity, heparin activation, and the efficiency of proteinase trapping as revealed by a P2 Gly --> Pro mutation.
    Chuang YJ; Gettins PG; Olson ST
    J Biol Chem; 1999 Oct; 274(40):28142-9. PubMed ID: 10497166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism by which exosites promote the inhibition of blood coagulation proteases by heparin-activated antithrombin.
    Izaguirre G; Swanson R; Raja SM; Rezaie AR; Olson ST
    J Biol Chem; 2007 Nov; 282(46):33609-33622. PubMed ID: 17875649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formation of a noncovalent serpin-proteinase complex involves no conformational change in the serpin. Use of 1H-15N HSQC NMR as a sensitive nonperturbing monitor of conformation.
    Peterson FC; Gordon NC; Gettins PG
    Biochemistry; 2000 Oct; 39(39):11884-92. PubMed ID: 11009600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The appended tail region of heparin cofactor II and additional reactive centre loop mutations combine to increase the reactivity and specificity of alpha1-proteinase inhibitor M358R for thrombin.
    Sutherland JS; Bhakta V; Sheffield WP
    Thromb Haemost; 2007 Nov; 98(5):1014-23. PubMed ID: 18000606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ternary complex of antithrombin-anhydrothrombin-heparin reveals the basis of inhibitor specificity.
    Dementiev A; Petitou M; Herbert JM; Gettins PG
    Nat Struct Mol Biol; 2004 Sep; 11(9):863-7. PubMed ID: 15311268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The P6-P2 region of serpins is critical for proteinase inhibition and complex stability.
    Chaillan-Huntington CE; Gettins PG; Huntington JA; Patston PA
    Biochemistry; 1997 Aug; 36(31):9562-70. PubMed ID: 9236002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of thrombin with antithrombin, heparin cofactor II, and protein C inhibitor.
    Whinna HC; Church FC
    J Protein Chem; 1993 Dec; 12(6):677-88. PubMed ID: 8136018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active site distortion is sufficient for proteinase inhibition by serpins: structure of the covalent complex of alpha1-proteinase inhibitor with porcine pancreatic elastase.
    Dementiev A; Dobó J; Gettins PG
    J Biol Chem; 2006 Feb; 281(6):3452-7. PubMed ID: 16321984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of serpin dysfunction in disease.
    Kaiserman D; Whisstock JC; Bird PI
    Expert Rev Mol Med; 2006 Dec; 8(31):1-19. PubMed ID: 17156576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory mechanism of serpins. Identification of steps involving the active-site serine residue of the protease.
    Stone SR; Le Bonniec BF
    J Mol Biol; 1997 Jan; 265(3):344-62. PubMed ID: 9018048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering D-helix of antithrombin in alpha-1-proteinase inhibitor confers antiinflammatory properties on the chimeric serpin.
    Yang L; Dinarvand P; Qureshi SH; Rezaie AR
    Thromb Haemost; 2014 Jul; 112(1):164-75. PubMed ID: 24522239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serine 380 (P14) --> glutamate mutation activates antithrombin as an inhibitor of factor Xa.
    Futamura A; Gettins PG
    J Biol Chem; 2000 Feb; 275(6):4092-8. PubMed ID: 10660568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.